Share

August 27, 2013; 81 (9) Editorial

Decisional capacity in cognitively impaired patients with Parkinson disease

Daniel C. Marson, Linda A. Hershey
First published July 26, 2013, DOI: https://doi.org/10.1212/WNL.0b013e3182a05ccd
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
136

Share

Article Information

vol. 81 no. 9 780-781
DOI: 
https://doi.org/10.1212/WNL.0b013e3182a05ccd
PubMed: 
23892707
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published July 26, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Daniel C. Marson, JD, PhD and
    2. Linda A. Hershey, MD, PhD
  1. Daniel C. Marson, JD, PhD and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Dr. Marson received honoraria for presentations from the following events from April 2011- present.

    Consultancies:

    1. Georgia Alzheimer's Association and Georgia Division of Aging Services

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Funded as primary investigator by NIH grants HD053074 (2007-present), AG021927 (2004-present) Funded as site PI for AG24904 (2004-2009), and two studies supported by AG10483 (2006-2012)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. Co-inventor of CCTI assessment instrument which is owned by UAB Research Foundation. (1996-present)

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Provided consultation: Flowers v. State of Alabama (2007-date). Peraita v. State of Alabama (2007-date). Estate of Rae S. Kimerling (2010) Albert R. Marcotte Family Trust (2010-2012) State v. Peraita (2010-2012) Harrison(2011) Estate of Richard Stockham (2012 to date) Matter of Matthew Davidson (2012 to date) Litigation involving Western Steel (2012 to date) Provided consultation in case of L. Crowe (2011) Provided

  2. Linda A. Hershey, MD, PhD
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. I have been paid an honorarium from the University of Central Oklahoma for giving a talk in the community about Alzheimer disease and other types of dementia.

    Editorial Boards:

    1. Dr. Hershey has served on the editorial board of Neurology since 2010.

    Patents:

    1. NONE

    Publishing Royalties:

    1. Dr. Hershey has received a royalty for writing a review for MedLink Neurology. Memory loss. In: “MedLink Neurology”, edited by Tim Greenamyer, MedLink Corporation, San Diego, CA, pp 1-20, 2013 (www.medlink.com).

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Dr. Hershey is the site PI for the Baxter study of IVIG in patients with mild-moderate Alzheimer disease (2012-2014).

    Research Support, Government Entities:

    1. VHA Health Sciences Research & Development.....I was Co-PI with Dr. Neale Chumbler, PhD (PI), “Health Information & Communication Strategies for Improving Stroke Care in the VA”, 2010-2011.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology (D.C.M.) and Alzheimer's Disease Center (D.C.M.), University of Alabama at Birmingham, Birmingham; and the Department of Neurology (L.A.H.), University of Oklahoma Health Sciences Center, Oklahoma City.
  1. Correspondence to Dr. Marson: dmarson{at}uab.edu
View Full Text

Article usage

Article usage: July 2013 to July 2022

AbstractFullPdfSource
Jul 20138008Highwire
Aug 20133211646Highwire
Sep 20131151023Highwire
Oct 20133634Highwire
Nov 20131246Highwire
Dec 2013603Highwire
Jan 20141447Highwire
Feb 2014833Highwire
Mar 20141601Highwire
Apr 20141300Highwire
May 2014502Highwire
Jun 20141000Highwire
Jul 2014600Highwire
Aug 2014300Highwire
Sep 2014512Highwire
Oct 2014700Highwire
Nov 2014411Highwire
Dec 20141512Highwire
Jan 20151010Highwire
Feb 2015001Highwire
Mar 20151632Highwire
Apr 2015800Highwire
May 2015011Highwire
Jun 20151100Highwire
Jul 20152300Highwire
Aug 20151000Highwire
Sep 20151100Highwire
Oct 2015111Highwire
Nov 2015912Highwire
Dec 2015711Highwire
Jan 20161000Highwire
Feb 2016700Highwire
Mar 2016801Highwire
Apr 2016500Highwire
May 2016200Highwire
Jun 2016800Highwire
Jul 2016662Highwire
Aug 20161000Highwire
Sep 20161101Highwire
Oct 2016800Highwire
Nov 2016400Highwire
Dec 2016700Highwire
Jan 2017500Highwire
Feb 2017701Highwire
Mar 2017400Highwire
Apr 20171100Highwire
May 2017501Highwire
Jun 2017700Highwire
Jul 2017100Highwire
Aug 2017100Highwire
Oct 2017201Highwire
Nov 2017200Highwire
Dec 2017300Highwire
Jan 2018801Highwire
Feb 2018211Highwire
Mar 2018521Highwire
Apr 20181000Highwire
May 20181700Highwire
Jun 20181710Highwire
Jul 2018701Highwire
Aug 20181101Highwire
Sep 2018300Highwire
Oct 20181100Highwire
Nov 20181000Highwire
Dec 2018900Highwire
Jan 2019400Highwire
Feb 2019210Highwire
Mar 2019300Highwire
Apr 20191010Highwire
May 20191810Highwire
Jun 20191400Highwire
Jul 20191101Highwire
Aug 2019600Highwire
Sep 2019200Highwire
Oct 20191500Highwire
Nov 20191100Highwire
Dec 20191010Highwire
Jan 20201300Highwire
Feb 2020912Highwire
Mar 2020400Highwire
Apr 2020500Highwire
May 2020700Highwire
Jun 20201000Highwire
Jul 2020800Highwire
Aug 2020700Highwire
Sep 2020200Highwire
Oct 2020200Highwire
Nov 20201410Highwire
Dec 2020700Highwire
Jan 2021600Highwire
Feb 2021811Highwire
Mar 20211200Highwire
Apr 20211901Highwire
May 2021500Highwire
Jun 2021900Highwire
Jul 20211200Highwire
Aug 2021700Highwire
Sep 2021900Highwire
Oct 2021300Highwire
Nov 20212110Highwire
Dec 2021400Highwire
Jan 20221200Highwire
Feb 20221400Highwire
Mar 20221211Highwire
Apr 20221501Highwire
May 2022400Highwire
Jun 2022600Highwire
Jul 2022901Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me